Azenta Q3 revenue flat at $144 million; net loss $52.8 million on $50 million impairment
Azenta reported fiscal third-quarter 2025 results for the quarter ended June 30, 2025. Revenue from continuing operations was $144 million, flat year over year, while adjusted EBITDA margin rose to 12.3% from 9.7%. A $50 million non-cash impairment charge tied to discontinued operations pushed total diluted EPS to ($1.15), and the company reiterated its full-year fiscal 2025 guidance.
Key points
- Revenue was $144 million, flat year over year; organic revenue declined 2%.
- Diluted EPS from continuing operations was $0.01 versus ($0.00) a year earlier; non-GAAP diluted EPS was $0.19 versus $0.14.
- Total diluted EPS was ($1.15) versus ($0.12), including ($1.17) from discontinued operations due to a $50 million non-cash impairment charge.
- Full-year fiscal 2025 guidance was reiterated: organic revenue growth of 3% to 5% and adjusted EBITDA margin expansion of about 300 basis points.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:54 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 05, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.